Vivanza Biosciences Limited (BOM:530057)
India · Delayed Price · Currency is INR 1.860
-0.060 (-3.12%)
At close: Jun 17, 2026
Vivanza Biosciences Market Cap
Vivanza Biosciences has a market cap or net worth of 74.4 million as of June 18, 2026. Its market cap has decreased by -22.18% in one year.
Market Cap
74.40M
Enterprise Value
175.67M
Revenue
1.16B
Ranking
n/a
PE Ratio
18.60
Stock Price
1.86
Market Cap Chart
Since October 23, 2012, Vivanza Biosciences's market cap has decreased from 178.64M to 74.40M, a decrease of -58.35%. That is a compound annual growth rate of -6.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 74.40M | -15.45% |
| Dec 31, 2025 | 88.00M | -35.67% |
| Dec 31, 2024 | 136.80M | -68.25% |
| Dec 29, 2023 | 430.80M | -30.96% |
| Dec 23, 2022 | 624.00M | -12.92% |
| Dec 27, 2021 | 716.60M | 59.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 13, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Colinz Laboratories | 146.74M |
| Ortin Global | 135.79M |
| Norris Medicines | 135.61M |
| Emmessar Biotech & Nutrition | 128.65M |
| Shamrock Industrial Company | 127.82M |
| Beryl Drugs | 116.14M |
| Unjha Formulations | 78.63M |
| Ganga Pharmaceuticals | 70.94M |